USANA Health Sciences (USNA) Misses Q1 EPS by 4c; outlook Reaffirmed

USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $1.77, $0.04 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $240.4 million versus the consensus estimate of $244.05 million.

Number of active Associates increased by 16.2% to 437,000.

USANA Health Sciences reaffirmed FY2016 guidance.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• 374Water Inc (SCWO) Misses Q2 EPS by 15c